N-(取代嘧啶-2'-基)-2-三氟乙酰氨基苯磺酰脲的合成及除草活性

磺酰脲类除草剂是近 2 0年来开发出的超高效、广谱、低毒和高选择性除草剂 .在已研究的磺酰脲分子中 ,芳环的邻位取代基多为酯基、卤素、取代烷氧基、三氟甲基等 [1,2 ] ,而邻位取代基为酰胺基的甚少 .为寻找高活性的磺酰脲化合物 ,本文将活性基团三氟乙酰氨基引入磺酰脲分子中 ,合成了 1 0种 N - (取代嘧啶 - 2 -基 ) - 2 -三氟乙酰氨基苯磺酰脲 (其中 9种为新化合物 ,4b～ 4j) ,并改进了实验方法 ,使产率明显提高 .同时还测定了它们的除草活性 ,其中一些化合物具有良好的活性 .合成路线如下 :　　 X- 4数字显示显微熔点仪 ,温度计未校正…     

新单取代苯磺酰脲衍生物的合成及生物活性

以较高活性的单取代苯磺酰脲为基础,设计合成了14个新的含烷硫基和烷胺基嘧啶环的单取代苯磺酰脲化合物,其结构经¹HNMR及元素分析确证.用油菜根长法测定IC₅₀,并进行盆栽除草活性测试,结果表明,嘧啶环4位取代基的变化对分子除草活性影响较大,活性大致按烷氧基、烷硫基和烷胺基的顺序递减.     

含嘧啶环的噻吩磺酰脲的合成和除草活性测定

从噻吩出发经4步反应合成了15种含嘧啶的噻吩磺酰脲N’-(4,6-二取代嘧啶-2-基)-2-噻吩磺酰脲,其中11种为未见文献报道的新化合物.其结构经红外光谱、~1H NMR谱和元素分析证实.初步生物活性试验表明,这类化合物具有较好的除草活性.     

三氟甲基嘧啶磺酰脲的合成与除草活性

以三氟乙酰乙酸乙酯和盐酸胍为原料,经环合、氯化、甲氧基化、胺化反应合成了4种2-氨基-4-取代-6-三氟甲基嘧啶中间体(Ⅰa~Ⅰd),Ⅰ与邻甲氧羰基苯磺酰异氰酸酯亲核加成,合成了3种含不同取代嘧啶环的磺酰脲化合物(Ⅱb~Ⅱd)。其中2-氨基-4-二甲胺基-6-三氟甲基嘧啶(Ⅰd)和N[-2-(′4-二甲胺基-6-三氟甲基)嘧啶基]-2-甲氧羰基苯磺酰脲(Ⅱd)为新化合物,结构经1H NMR和MS表征。初步除草活性测定结果表明,N-[2-′(4-甲氧基-6-三氟甲基)嘧啶基]-2-甲氧羰基苯磺酰脲(Ⅱc)在浓度为200 ga.i./ha时对稗草和马唐的防效分别为70%和50%。     

新(4′-三氟甲基嘧啶基)-2-苯磺酰脲衍生物的合成及生物活性

以单取代苯磺酰脲除草剂NK92825和NK94827为基础,将三氟甲基引入嘧啶环中,设计合成了17个新的4′-三氟甲基嘧啶苯磺酰脲化合物,产物结构均经1H NMR及元素分析确证.目标化合物经盆栽试验,结果表明,部分化合物有较好的除草活性.     

苯环2-位不同酯基取代的磺酰脲类化合物的合成及其除草活性

以正在开发的磺酰脲类超高效除草剂NK94827[N'-(4'-甲基嘧啶-2'-基)-2-甲氧羰基苯磺酰脲]的基本结构为基础,设计合成了18个苯环2位不同酯基取代的的新型磺酰脲类化合物,产物结构均经¹HNMR及元素分析确证.经油菜平皿法和盆栽试验测试除草活性,所合成的部分磺酰脲化合物的除草活性高.     

新磺酰脲类化合物的合成及生物活性

以正在开发的新磷磺酰脲除草剂N-[2′-(4′-甲基)嘧啶基]-2-硝基苯磺酰脲的研究为基础,设计合成了19个脲桥经修饰的磺酰脲类化合物以及3个新型嘧啶中间体,产物结构经¹HNMR谱及元素分析确证.盆栽试验和离休ALS酶研究结果表明,所合成的化合物均表现出一定的除草活性,部分化合物的除草活性较好.     

2-甲基-6-氯苯基磺酰脲衍生物的合成及生物活性

为探索磺酰脲类化合物的生物活性多样性,以商品化磺酰脲除草剂为基础,设计并合成了12个未见文献报道的2-甲基-6-氯苯基磺酰脲衍生物,通过1H NMR,13C NMR和HRMS确定了其结构.经盆栽法除草测试表明,目标化合物对双子叶靶标油菜和反枝苋具有优异的的除草活性,如5b,5i和5j对油菜和稗草的除草活性与氯磺隆和单嘧磺隆相当.离体抑菌实验表明,在50 mg·L-1剂量下,部分化合物对所测试植物性病菌具有不错的抑菌活性.     

新三取代嘧啶苯磺酰脲衍生物的合成与生物活性

设计合成了22个具有4,5,6-三取代嘧啶磺酰脲衍生物, 其结构经1H NMR, MS和元素分析确证. 经盆栽试验测定了化合物的除草活性, 结果表明, 嘧啶环5位取代基的引入对分子除草活性有一定的影响.     

含嘧啶环的苯基磺酰脲、吡唑磺酰脲的合成及生物活性

磺酰脲衍生物;除草活性;含嘧啶环的苯基磺酰脲、吡唑磺酰脲的合成及生物活性     

Studies of the synthesis and thermochemistry of coordinatively unsaturated chelate complexes (eta 5-C5Me5)IrL2 (L2 = TsNCH2CH2NTs, TsNCH2CO2, CO2CO2)

A comparative synthetic, structural, and thermochemical study on a series of chelate complexes containing the fragment (eta 5-C5Me5)Ir [(eta 5-C5Me5)Ir(TsNCH2CH2NTs) (1), (eta 5-C5Me5)Ir(TsNCH2CO2) (2), (eta 5-C5Me5)Ir(CO2CO2) (3)] was performed to clarify the roles of carboxylato and sulfonamido ligands. Whereas 1 and 2 are monomeric in solution and in the solid state, 3 appears to exist as an oligomer or polymer, (3)n, which can be broken up by addition of a ligand L such as a phosphine, CO, or 2-methoxypyridine to form (eta 5-C5Me5)Ir(L)(CO2CO2) (6). The synthesis of (3)n from [(eta 5-C5Me5)IrCl(mu-Cl)]2 required the use of silver oxalate in CH3CN, but if other solvents were used, the bridging oxalato complex (eta 5-C5Me5)IrCl(mu-eta 2-eta 2-C2O4)ClIr(eta 5-C5Me5) (7) was obtained and identified by X-ray diffraction. Enthalpies for reaction of THF-soluble monomers 1 and 2 with PMe3 were determined to be -28.7(0.5) and -28.5(0.4) kcal mol-1, respectively. The oligomerization behavior of 3 may be a result of reduced sigma- or pi-donation of carboxylato ligands compared to N-tosylamido ligands, because the values for nu CO in oxalato and bissulfonamido complexes 6-CO and (eta 5-C5Me5)Ir(CO)(TsNCH2CH2NTs) (4-CO) were 2064 and 2042 cm-1, respectively.     

2-(5-Bromo-2-furyl)quinoxaline and 3-(5-bromo-2-furyl)-2-quinoxalone

2-(5-Bromo-2-furyl)quinoxaline and 3-(5-bromo-2-furyl)-2-quinoxalone were obtained by the action of bromine on the corresponding quinoxaline derivatives and also by condensation of o-phenylenediamine with, respectively, (5-bromo-2-furyl)glyoxal or (5-bromo-2-furyl)glyoxylic acid esters.Translated from Khimiya Geterotsiklicheskikh Soedinenii, No. 3, pp. 404–406, March, 1973.     

Oxetane from A-nor-steroides: 2-alpha, 5-oxido-A-nor-5-alpha-cholestane, 2-beta, 5-oxido-A-nor-5-beta-cholestane and 2-alpha-ethyl-2-beta,2'-oxido-A-nor-5-alpha-cholestane

Treatment of 2β-tosyloxy-A-nor-5α-cholestane-5-ol ( 2 ) with t-butoxide in t-butanol gave 2α, 5-epoxy-A-nor-5α-cholestane ( 3 ) in quantitative yield. When A-nor-5β-cholestane-2α, 5-diol ( 4 ) was treated with tosyl chloride in pyridine 2β-chloro-A-nor-5β-cholestane-5-ol ( 7 ) and 2α-tosyloxy-A-nor-5β-cholestane-5-ol ( 8 ) were obtained. Whereas the chloride 7 was resistant to t-butoxide the tosylate 8 was transformed into an 1 : 1 mixture of 2α, 5-epoxy-5β-cholestane ( 10 ) and 2ξ-t-butoxy-A-nor-5β-cholestane-5-ol ( 11 ). In 2α-tosyloxy-A-nor-5α-cholestane-5-ol ( 12 ) substitution occurred as the only reaction. Both oxetanes 3 and 10 isomerize after heating above 50° and in polar or protic solvents to form A-nor-Δ³⁽⁵⁾-cholestene-2α-ol ( 6 ) and -2β-ol ( 14 ) respectively. Also, 2, 5-diols are encountered. 2α-Ethyl-2β, 2′-epoxy-A-nor-5α-cholestane ( 23 ) was synthesized starting from A-nor-5α-cholestane-2-one ( 17 ). The intermediates were the ester 16 , the diol 18 , the hydroxy-tosylate 19 and the chlorhydrin 20 . The spirocyclic oxetane 23 was reduced by LiAlH₄ in dioxane (not in ether). By chromatography on silica gel 23 was isomerized to the homoallylic alcohol 21 and transformed into 2-methylene-A-nor-5α-cholestane ( 24 ) by fragmentation. The IR. and NMR. spectra of the new oxetanes were compared with those of a series of known oxetanes.     

五配位阴离子型有机锡化合物的合成及[C5H5NH][Ph2Sn(μ2-SCH2COO)Cl]和[CH3PhNH2][Ph2Sn(μ2-SCH2COO)Cl]晶体结构

近年来，由于离子型有机锡化合物的分子结构的多样性、较好的生物活性以及在有机合成上的应用，而引起广泛注意，前文报道了Ph3SnCl与HSCH2COOH在有机胺存在下发生Sn-Ph键断裂，生成二苯基锡的离子型有机锡化合物，本文用Ph2SnCl2与HSCH2COOH在有机胺存在下，采用同样的反应条件Sn-Ph键不再断裂，得到与前文结构相类似的化合物，反应方程式如下：     

尾式卟啉H2[5-Br-PADAPBPP]及其Pd2+,Ni(bpy)2+配合物的合成

合成了新的尾式-5-{2-[(5-溴-2-吡啶)偶氮-]5-(二乙氨基)苯氧基}对丁氧基苯基-10,15,20-三苯基卟啉{H2[5-Br-PADAPBPP]}及其Pd2 和Ni(bpy)2 配合物,其结构经UV,1HNMR,IR和元素分析表征。     

5-取代吲哚-2-酮的合成

4-取代苯胺依次与水合氯醛及盐酸羟胺反应制得4-取代异亚硝基乙酰苯胺(2a～2e);2在浓硫酸作用下环合制得5-取代靛红(3a～3e);3通过改进的Wolff-Kishner-黄鸣龙反应合成了重要的药物中间体——5-取代吲哚-2-酮(5a～5e);5a通过硝化制得5-硝基吲哚-2-酮(5f);5f被还原制得5-氨基吲哚-2-酮(5g)。其结构经1H NMR和MS确证。     

5-Aryl-2-furaldehydes in the Synthesis of 2-Substituted 1,3-Benzazoles

2-[2-(5-Aryl-2-furyl)ethenyl]-1,3-benzazoles were synthesized by reaction of 5-aryl-2-furaldehydes with 2-methylbenzoxazole, 2-methylbenzothiazole, 2-methylbenzimidazole, and 2-cyanomethylbenzimidazole. The corresponding benzazoles were also obtained by reaction of N-(5-arylfurfurylidene)anilines with 2-methylbenzoxazoles and of 3-(5-aryl-2-furyl)-2-cyanopropenoyl chlorides with o-phenylenediamine. The acylation of o-aminophenol with 3-(5-aryl-2-furyl)-2-cyanopropenoyl chlorides occurs at the amino group without subsequent oxazole ring closure.     

5-芳酰氨基-2-苯基-2H-1, 2, 4-噻二唑-3-酮的合成

用1-芳酰基-5-苯基-2-硫代双脲与溴进行氧化成环反应制备了九个新的5-芳酰氨基-2-苯基-2H-1, 2, 4-噻二唑-3-酮, 相应的1-芳酰基-5-苯基-2-硫代双脲可以通过苯基脲与酰基异硫氰酸酯加成制得。     

Synthesis of 2-aminobenzoxazoles and 2-iminobenzoxazolines

The cyclization of sulfonamide derivatives of alkylated 2-hydroxyphenylthioureas in the presence of an ammoniacal solution of silver oxide gives 2-alkylaminobenzoxazole-5-sulfonamides or the corresponding 3-alkyl-2-alkyliminobenzoxazolines. Alkyl-substituted 2-aminobenzoxazole-5-sulfonamides were also obtained by the reaction of benzoxazolylthione with secondary amines and aniline.Translated from Khimiya Geterotsiklicheskikh Soedinenii, No. 2, pp. 173–174, February, 1976.     

Synthesis and transformations of 2-(2-furyl)-and 2-[β-(2-furyl)vinyl]imidazo[4,5-b]phenazines

The corresponding 2-(2-furyl)- and 2-[-(2-furyl)vinyl]imidazo[4,5-b]phenazines were obtained by the condensation of 2,3-diaminophenazine with furfural and 2-furylacrolein and with their 5-bromo and 5-nitro derivatives. The phenazines were also synthesized by the reaction of 2-methylimidazo[4,5-b]phenazine with furfural and 5-bromo- and 5-nitrofurfural. The alkylation, acetylation, and nitration of the compounds obtained, as well as replacement of the halogen in the furan ring by a nitro group, were studied.Translated from Khimiya Geterotsiklicheskikh Soedinenii, No. 10, pp. 1425–1428, October, 1971.